The U.S. Department of Veterans Affairs (VA) is launching a new trial on whether MDMA-assisted therapy can help military veterans who are struggling with severe mental health disorders, including PTSD and alcohol use disorder.
The study will involve approximately 80 veterans and will compare outcomes between those who take MDMA and undergo psychotherapy and those in a control group who receive identical psychotherapy without the drug.
“We need an all-of-the-above strategy when it comes to improving mental health treatments, and under President Trump, that’s exactly what VA is working to deliver,” VA Secretary Doug Collins said in a press release on Tuesday. “This trial represents an important step in safely evaluating new approaches and innovations to treat Veterans with severe mental health conditions.”
The research, which comes on the heels of an executive order President Donald Trump signed last month with the aim of expediting psychedelic therapy access, will take place at VA Providence Healthcare System in Rhode Island.
VA’s press release says the health and safety of veterans who participate is the department’s “top priority.”
“Investigational treatments will be delivered in a safe, controlled, clinical setting using pharmaceutical grade drugs under careful quality controls, stringent safety protocols that were
Read full article on Marijuana Moment
